Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: Relevance to theories of narcosis

Anesthesia and Analgesia

Volumn 88, Issue 4, 1999, Pages 867-876

  Eger II, Edmond I ^a   Ionescu, Pompiliu ^a   Laster, Michael J ^a   Gong, Diane ^a   Hudlicky, Tomas ^c   Kendig, Joan J ^d   Harris, R Adron ^b   Trudell, James R ^c   Pohorille, Andrew ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Stanford University ^*  (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANOL; SEVOFLURANE;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG SOLUBILITY; FLUORINATION; HYDROPHILICITY; INHALATION ANESTHESIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID SOLUBILITY; LIPOPHILICITY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032922658     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199904000-00035     Document Type: Article

References (33)

1. Meyer HH. Theorie der Alkoholnarkose. Arch Exp Pathol Pharmakol 1899;42:109-18.
2. Overton E. Studien über die Narkose, Zugleich ein Beitrag zur allgemeinen Pharmakologie. Jena: Gustav Fischer, 1901.
3. Taheri S, Halsey MJ, Liu J, et al. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991;72:627-34.
4. Koblin DD, Chortkoff BS, Laster MJ, et al. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994;79:1043-8.
5. Liu J, Laster MJ, Koblin DD, et al. A cut-off in potency exists in the perfluoroalkanes. Anesth Analg 1994;79:238-44.
6. Pohorille A, Cieplak P, Wilson MA. Interactions of anesthetics with the membrane-water interface. Chem Phys 1996;204: 337-45.
7. Eger EI II, Koblin DD, Harris A, et al. Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg 1997;84:915-8.
8. Chipot C, Wilson MA, Pohorille A. Interactions of anesthetics with the hexane-water interface. J Phys Chem 1996;101:782-91.
9. Pohorille A, Wilson MA, Cieplak P. Interaction of alcohols and anesthetics with the water-hexane interface: a molecular dynamics study. Prog Colloid Polym Sci 1997;103:29-40.
10. Fang ZX, Ionescu P, Chortkoff BS, et al. Anesthetic potencies of n-alkanols: results of additivity studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 1997;84:1042-8.
11. Fang ZX, Gong D, Ionescu P, et al. Maturation decreases ethanol MAC more than desflurane MAC in rats. Anesth Analg 1997; 85:852-8.
12. Fang Z, Ionescu P, Gong D, et al. Maturation decreases ethanol MAC in mice, as previously demonstrated in rats: there is no species difference. Anesth Analg 1997;85:160-3.
13. Eger EI II, Johnson BH. MAC of I-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg 1987;66:974-6.
14. Laster MJ, Liu J, Eger EI II, Taheri S. Electrical stimulation as a substitute for the tail clamp in the determination of MAC. Anesth Analg 1993;76:1310-2.
15. Liu J, Laster MJ, Taheri S, et al. Is there a cutoff in potency for the normal alkanes? Anesth Analg 1993;77:12-8.
16. Yoshimoto K, Komura S. Monitoring of ethanol levels in the rat nucleus accumbens by brain microdialysis. Alcohol Alcohol 1993;28:171-4.
17. Waud DR. On biological assays involving quantal responses. J Pharmacol Exp Ther 1972;183:577-607.
18. Taheri S, Laster MJ, Liu J, et al. Anesthesia by n-alkanes not consistent with the Meyer-Overton hypothesis: determinations of the solubilities of alkanes in saline and various lipids. Anesth Analg 1993;77:7-11.
19. Eger EI II, Liu J, Koblin DD, et al. Molecular properties of the "ideal" inhaled anesthetic: studies of fluorinated methanes, ethanes, propanes and butanes. Anesth Analg 1994;79:245-51.
20. Wick MJ, Mihic SJ, Ueno S, et al. Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci USA 1998;95:6504-9.
21. Smart BE. Characteristics of C-F systems. In: Banks RE, Smart BE, Tatloov K, eds. Organofluorine chemistry: principles and commercial applications. New York: Plenum, 1994:57-88.
22. Bunn CW, Howells ER. Structures of molecules and crystals of fluorocarbons. Nature 1954;174:549-51.
23. Smith GD, Jaffe RL, Yoon DY. Conformational characteristics of poly(tetrafluoroethylene) chains based upon ab initio electronic structure calculations on model molecules. Macromolecules 1994;27:3166-73.
24. 16 segment monitored by fluorescence. J Am Chem Soc 1990;112:2821-3.
25. Hansch C, Vittoria A, Silipo C, Jow PY. Partition coefficients and the structure-activity relationship of the anesthetic gases. J Med Chem 1975;18:546-8.
26. Fang Z, Laster MJ, Ionescu P, et al. Effects of inhaled nonimmobilizer, proconvulsant compounds on desflurane minimum alveolar anesthetic concentration in rats. Anesth Analg 1997;85: 1149-53.
27. Ueno D, Trudell JR, Eger EI II, Harris RA. Actions of fluorinated alkanols on GABAA receptors: relevance to theories of narcosis. Anesth Analg 1999;88:877-83.
28. Yost CS, Hampson AJ, Leonoudakis D, et al. Oleamide potentiates benzodiazepine-sensitive γ-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Anesth Analg 1998;86:1294-300.
29. Wallin RF, Regan BM, Napoli MD, Stern IJ. Sevoflurane: a new inhalational anesthetic agent. Anesth Analg 1975;54:758-65.
30. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981;54:100-6.
31. Kharasch ED, Karol MD, Lanni C, Sawchuk R. Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology 1995;82:1369-78.
32. Eger EI II, Bowland T, Ionescu P, et al. Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-hour exposure, including kinetics of degradation products. Anesthesiology 1997;87:517-26.
33. Payne AK, Morgan SE, Gandolfi AJ, Brendel K. Biotransformation of sevoflurane by rat neonate liver slices. Drug Metab Dispos 1995;23:497-500.